CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC
NCT04457700 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 218
Last updated 2022-04-18
Summary
This is a prospective, single-center, non-randomized, non-controlled observational study.
Conditions
- Triple-negative Breast Cancer
- HER2-positive Breast Cancer
Sponsors & Collaborators
-
Peking University
lead OTHER
Principal Investigators
-
Lize Wang, MD · Breast center at Peking University Cancer Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-01
- Primary Completion
- 2022-07-30
- Completion
- 2022-12-30
Countries
- China
Study Locations
More Related Trials
-
PET/MR Radiomics for Breast Cancer Diagnosis
NCT05466760 ·Status: UNKNOWN
-
Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology
NCT05441098 ·Status: UNKNOWN
-
68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer
NCT06559371 ·Status: RECRUITING
-
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women
NCT04996615 ·Status: UNKNOWN
-
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast Cancer
NCT05243121 ·Status: UNKNOWN
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Young Breast Cancer Patients
NCT04145986 ·Status: UNKNOWN
-
Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images
NCT06510738 ·Status: NOT_YET_RECRUITING
-
Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)
NCT05574907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery
NCT04145973 ·Status: UNKNOWN
-
The Value of High-resolution Ultrasound in the Detection of Lymph Node Metastasis: a Proposal of NI-RADS
NCT03791840 ·Status: COMPLETED
-
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NCT06879704 ·Status: RECRUITING ·Phase: NA
-
Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
NCT04003558 ·Status: UNKNOWN
-
Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy
NCT05301790 ·Status: UNKNOWN
-
Light-CT in the Diagnosis of Breast Tumor and Lymph Node
NCT03791853 ·Status: UNKNOWN
-
Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging
NCT04767659 ·Status: RECRUITING ·Phase: NA
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN
-
Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining
NCT06486155 ·Status: NOT_YET_RECRUITING
-
Prospective Ultrafast MRI Radiomics for Breast Cancer
NCT06104189 ·Status: COMPLETED
-
Multimodal Imaging Evaluation System of Axillary Lymph Node Staging and Treatment Strategy for Breast Cancer Neoadjuvant Therapy
NCT04661436 ·Status: UNKNOWN
-
Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT06856616 ·Status: ACTIVE_NOT_RECRUITING
-
Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer
NCT07179744 ·Status: RECRUITING
-
Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy
NCT01257152 ·Status: COMPLETED
-
CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer
NCT02992067 ·Status: COMPLETED
-
Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node Metastasis
NCT05768451 ·Status: UNKNOWN